The ever-expanding number of genes that are mutated in autism is showing us how imbalances in fundamental cellular processes can lead to disease. A recent study by T arlungeanu et al. (2016) identifies a form of ASD resulting from a failure of the brain to properly import amino acids.
Decades of genetic studies on neurodevelopmental disorders, including autism spectrum disorder (ASD) and intellectual disability (ID), have revealed genetic disruptions to a variety of processes that maintain neuronal health and promote circuit assembly. In fact, ASD and ID likely comprise a constellation of disorders with distinct genetic causes, each affecting neurons in different ways. Several hundred genes have now been implicated in ASD with varying degrees of certainty. Functional analyses in cell lines and animal models have begun to define possible gene categories and shared molecular deficits across ASD genes, often identifying broad regulatory functions.
Much of our understanding of the physiological and molecular correlates of ASD come from studies of syndromic conditions, where ASD is accompanied by ID and other neurological or clinical findings. This work has identified disruptions in the regulation of global gene transcription and protein synthesis in several forms of syndromic ASD, which has led to the hypothesis that a key cause of ASD and ID may be the disruption in homeostatic control of neuronal function, i.e., the ability of a neuron to reliably respond to electrical and molecular stimuli and return to a set point (Sztainberg and Zoghbi, 2016) . In a recent set of studies, Gaia Novarino and colleagues have identified a critical role for amino acid homeostasis in ASD, ID, and seizures (Novarino et al., 2012; T arlungeanu et al., 2016) , revealing a novel target that could modulate protein synthesis, energy production, and neurotransmission at the same time.
Amino acids are the building blocks of every protein in the cell, but they are also used as neurotransmitters and as metabolic intermediates in multiple pathways. By studying two related forms of syndromic ASD-one caused by mutations in branched chain ketoacid dehydrogenase kinase (BCKDK) (Novarino et al., 2012 ) and a second caused by a mutation in a component of the large neutral amino acid trasporter 1 (LAT1), SLC7A5 ( Figure 1A ) (T arlungeanu et al., 2016) -these studies showed how levels of branched chain amino acids (BCAAs) are critical for neuronal health. BCAAs, which include leucine, isoleucine, and valine, are essential amino acids that comprise as much as 30% of proteins. They are metabolized in the liver, skeletal muscle, heart, and adipose tissue via a multi-step process, leading to acetoacetate, acetyl-CoA, and succinyl-CoA, which are critical for ATP production ( Figure 1B ). After the initial transamination of BCAAs to branched-chain ketoacids (BCKAs), BCKDK controls activity of the second enzyme in BCAA metabolism, the branched chain ketoacid dehydrogenase complex (BCKDC). LAT1 in turn controls brain levels of both BCAAs and large neutral amino acids, including tyrosine and phenylalanine, which are precursors of serotonin and catecholamines. Thus, by affecting protein synthesis, energy production, and neurotransmitter balance, disruption of BCAA levels by BCKDK and SLC7A5 (LAT1) mutations has far-reaching implications for survival and function of several neuronal circuits. Since BCAAs can be supplemented or removed from the diet, this finding suggests that there may be a subset of ASD cases that is treatable by simple dietary interventions.
The importance of controlled BCAA levels during brain development first became evident in a severe metabolic condition, maple syrup urine disease (MSUD), so called because of the distinct syrupy, burnt sugar smell of urine from the affected infants. MSUD is caused by mutations decreasing activity of BCKDC, preventing ketoacid breakdown, and greatly increasing levels of both BCAAs and BCKAs. Accumulation of leucine, in particular, is extremely neurotoxic through multiple mechanisms. As LAT1 is an obligate 1:1 exchanger, coupling one amino acid influx with one amino acid efflux ( Figure 1A ), hyperleucinemia causes an imbalance in other essential amino acids, including glutamate, and reduces dopamine and serotonin tone. In addition, osmotic dysregulation can cause brain edema. The most severe forms of MSUD present a few days after birth with convulsions, ketoacidosis, and acute encephalopathy and, if untreated, progress to coma and death. Reduced BCAA infant formula or liver transplant to restore BCAA metabolism have proven effective, but even with treatment, MSUD confers a high risk of ID and multiple psychiatric presentations, including depression, anxiety, and attention deficit hyperactivity disorder (ADHD) (Muelly et al., 2013) . These findings suggest that inability to maintain homeostasis of BCAA levels in the brain may lead to a variety of neurodevelopmental disorders.
The identification of BCKDK mutations in families with ASD, ID, and seizures showed that lower BCAA levels could also be deleterious for brain development. Loss of BCKDK leads to amino acid imbalance in the brain of Bckdk knockout (KO) mice (Novarino et al., 2012) and in both plasma and cerebrospinal fluid of patients with BCKDK mutations (García-Cazorla et al., 2014 Unlike Bckdk, Slc7a5 is primarily found in the endothelial cells that form the vasculature of the mature brain. As the brain matures, endothelial cells come together to form the robust vascular structures of the blood-brain barrier (BBB), which controls the flow of amino acids and other nutrients into the brain. Complete Slc7a5 loss of function is embryonically lethal, suggesting an essential function throughout development and in other tissues. To bypass embryonic lethality and explore the role of Slc7a5 in amino acid trafficking through the BBB, T arlungeanu et al. (2016) used a conditional approach to specifically ablate the gene in endothelial cells (Slc7a5 cKO). During early postnatal development, when the vasculature is still ''leaky,'' deletion of Slc7a5 had virtually no observable defects. However, as the brain matured, a severe reduction of BCAAs was observed, similar to the Bckdk KO mice. Interestingly, BCAA levels began to decline in correspondence with an increase in histidine, which may participate in the 1:1 exchange flowing through LAT1 opposite to BCAAs. Histidine increases as much as 3-fold in the adult brain, but it remains unclear whether this causes any molecular deficits.
Slc7a5 cKO mice perform poorly on tests of social interaction and show impairments in gait and motor coordination that are suggestive of a broader ASDrelated syndrome, similar to that observed with BCKDK/Bckdk mutations (García-Cazorla et al., 2014; Novarino et al., 2012) . Intraventricular injection of leucine and isoleucine in the brain of Slc7a5 cKO mice was able to rescue the motor deficits, but further studies will be needed to address how this treatment affects social behavior. Slc7a5 deficiency was also associated with anomalies in cortical neuron function, including increased excitatory and decreased inhibitory miniature synaptic events, and a measurable decrease in presumptive inhibitory synaptic vesicles. Thus, reduced BCAA influx caused by mutations in either BCKDK or SLC7A5 causes motor and social deficits (2016) found that this gene is mutated in a syndromic form of autism spectrum disorder (ASD) associated with alterations in branched-chain amino acids (BCAAs) in the brain (see ''SLC7A5 mutations'' inset in gray). (B) BCAAs are metabolized through the BCAA aminotransferase (BCAT) and the branched-chain alphaketo acid transferase (BCKD) to feed metabolites into multiple pathways, including the tricarboxylic acid (TCA) cycle or Krebs cycle. BCKD kinase (BCKDK) mutations directly affected this pathway and cause a reduction in BCAA levels associated with disease (see ''BCKDK mutations'' gray inset). (C-E) BCAA reduction can also be sensed via the leucine sensor Sestrin 2 to modulate the mTor pathway (C) or via the free transfer (t)RNA sensing pathway (D), leading to dysregulation of protein synthesis (E).
in both mice and humans. BCAA supplementation deserves further testing as an intervention to rescue psychomotor phenotypes associated with ASD.
Since faulty amino acid homeostasis can wreak havoc on the brain through a variety of mechanisms, T arlungeanu et al. (2016) started their functional studies by assessing global changes in transcription in the Slc7a5 mutant brain. The results showed a series of cellular responses to the lack of specific amino acids, including the upregulation of other amino acid transporters. Upregulation of other transporters with overlapping affinity may help to blunt the effects of Slc7a5 loss of function, limiting the extent of the amino acid deficiency. These changes fall into the general category of the cellular amino acid response (AAR) mechanism, which represents the cellular attempt to compensate for amino acid starvation ( Figures 1C and 1D ).
When confronted with a lack of nutrients, a cell can react by engaging several overlapping mechanisms. Since BCAAs cannot be produced by mammals, cells are forced to regulate other aspects of cellular metabolism and function, limiting energy usage, modulating production and degradation of proteins and organelles, or, in the most extreme case, committing cellular suicide (apoptosis). The Slc7a5 cKO brain displays one of these key responses: blocking the initiation of cap-dependent protein translation ( Figure 1E ). This post-transcriptional slowdown in the production of proteins is shown by assessing the fraction of RNA bound to ribosomes (polysomes). In the mutant brains, less mRNA is bound to actively translating ribosomes, suggesting that brain cells are restricting amino acid usage by slowing protein synthesis. This phenomenon appears to be signaled by the activation of the ''General Control Non-derepressible 2'' (GCN2) pathway, as indicated by increased phosphorylation of a modulator of translation, eIF2a. GCN2 is activated by the overabundance of uncharged transfer RNA (tRNA)-a signal that there are insufficient amino acid building blocks for protein translation ( Figure 1D ).
While the GCN2 pathway is an important response mechanism for amino acid starvation, it is not the only one. Thus, it is somewhat surprising that there was no evidence of changes in mammalian target of rapamycin (mTOR) signaling, the other canonical response pathway for amino acid deficiency ( Figure 1C) . In particular, a protein complex-referred to as mTORC1-is known as a key response for multiple stressors, including nutrient starvation, by acting as a sort of ''throttle'' for cellular metabolism. Previous work has shown that a reduction in leucine reduces the activation of Sestrin 2, a leucine-dependent mTOR activator, causing a robust reduction in mTORC1 signaling (Wolfson et al., 2016) . However, despite a clear reduction in leucine, Slc7a5 cKO brains showed no changes to the phosphorylation of p70-S6K, a canonical readout of mTORC1 signaling. While there was a change in the phosphorylation of a second mTORC1 target, eIF4EBP1, this lack of canonical mTOR signaling is confounding. Previous work has suggested that the GCN2 pathway significantly overlaps with the mTOR pathway-and, in fact, GCN2 activation can repress mTORC1 (Averous et al., 2016) . Thus, the response to cellular starvation is robust, but it does not involve the ''usual suspects.''
The mechanisms by which mTORC1 signaling is left unscathed by Slc7a5 removal in the BBB remain to be defined. One possibility is that aspects of the response to amino acid deficiency may be largely invisible to transcriptional profiling. mTOR signaling, GCN2, and other cellular stress signaling pathways are primarily ''phosphorylation cascades,'' with their effects mediated by activated kinases phosphorylating and activating other downstream kinases in a transient manner. Alternatively, the cellular response observed in the brain may be a peculiarity that is not readily predicted by the numerous previous studies of amino acid signaling that were performed in cell lines or model systems such as yeast. Neurons and glia are metabolically quite distinct from transformed cells or cells derived from other tissues. Since neurons are non-proliferating cells, their cellular stress responses to amino acid starvation and subsequent mTOR activation could be different from those of proliferating cells.
Protein translation disruptions have been described in multiple models of syndromic ASD (Santini and Klann, 2014) , but these are usually seen alongside alterations in the mTOR pathway. Some of the best studied models of syndromic ASD are the so-called ''Tor-opathies,'' where mTOR signaling intermediates are genetically disrupted, but unlike in the brain of Slc7a5 cKO mice, these mutations lead to an uncontrolled increase in protein translation. This link between syndromic ASD and increased translation is also observed in several other genetic models of ASD that do not directly engage the mTOR signaling pathway, including Fmr1 mutation (Fragile X syndrome) and eIF4BP2 deletion, suggesting that dysregulated translation may be central to ASD-relevant behavioral deficits (Darnell et al., 2011; Gkogkas et al., 2013) . In fact, the linkage between uncontrolled translation and ASD is strong enough that pharmacological inhibitors of translation are being considered as targets for intervention for multiple forms of ASD (Crunkhorn, 2013) . The identification of reduced translation in the brain of Slc7a5 cKO mice raises the possibility that too much or too little protein synthesis may lead to similar phenotypes.
One possible explanation is that the focus on the immediate signaling response to BCAA deficiency overlooks other downstream consequences of amino acid starvation, such as the production of defective proteins. In fact, amino acid starvation may share a common pathology with the uncontrolled over-translation of proteins seen in other ASD models. When essential amino acids are lacking, the defective cell machinery is unable to provide necessary aminoacyltRNAs in sufficient amounts to meet synthetic demand, leading to translation errors. If such defective proteins begin to accumulate, it could trigger other stress responses that are distinct from mTOR signaling, such as the unfolded protein response (UPR). It is possible that the numerous disruptions identified in syndromic forms of ASD are inhibiting the normal cellular responses that protect the integrity of protein translation, although by diverse means.
In conclusion, the discovery that defects in amino acid homeostasis and metabolism are linked to ASD identified an easily manipulation via dietary supplementation, which should be investigated in other forms of syndromic and non-syndromic ASD. The molecular mechanisms by which reduced BCAA levels disrupt motor function and social behavior remain poorly understood. This work from T arlungeanu et al. (2016) opens multiple novel paths for investigation on how amino acids contribute to normal and diseased brain development.
